期刊文献+

《中国中药杂志》发表的干预类系统评价/Meta分析的报告质量评价研究 被引量:8

Report quality evaluation of systematic review or Meta-analysis published in China Journal of Chinese Materia Medica
原文传递
导出
摘要 评价《中国中药杂志》上发表的干预类系统评价/Meta分析的报告质量。电子检索CNKI数据库和《中国中药杂志》官方网址,收集自创刊以来刊载的干预类系统评价/Meta分析,共纳人40篇,其中有l篇为网状Meta分析。根据2009年发表的PRISMA声明评价纳入系统评价/Meta分析的报告质量,3篇为低质量,30篇为中等质量,7篇为高质量。所有条目平均得分为30分(中等质量2l~30.5分)。高质量(3l-40分)报告条目17个:标题、理论基础、目的、信息来源、研究选择、资料提取、资料条目、单个研究存在的偏倚、概括效应指标、研究偏倚、研究选择、研究特征、研究内部偏倚风险、单个研究结果、结果的综合、研究间偏倚、资金;中等质量(2l-30.5分)报告条目4个:纳入标准、检索、局限性、结论;低质量(≤20.5分)报告条目6个:结构式摘要、方案和注册、结果综合、其他分析(条目16)、其他分析(条目23)、证据总结。通过分析发现,《中国中药杂志》上发表的干预类系统评价/Meta分析的报告质量中等,有必要提高报告质量规范。 To evaluate the report quality of intelwention-related systematic reviews or Meta-analysis published in China Journal of Chinese Materia Medica, we searched CNKI and China Journal of Chinese Materia Medica webpages to collect intervention-related sys- tematic reviews or Meta-analysis since the first issue of the magazine. A total of 40 systematic reviews or Meta-analysis reports were in- cluded, including one network Meta-analysis. According to the PRISMA statement published in 2009, the report quality of the system- atic reviews or Meta-analysis was evaluated. According to the results, 3 had the low quality, 30 had the medium quality, and 7 had the high quality. The average score for all of items was 30 points (21-30. 5 points for the medium quality). The 17 high-quality (31-40 points) report items were title, rationale, objectives, information sources, study selection, data collection process, data items, risk of bias in individual studies, summary measures, risk of bias across studies, study selection, study characteristics, risk of bias within studies, results of individual studies, synthesis of resuhs, risk of bias across studies and funding; the 4 medium-quality (21-30. 5 points) reporting items were eligibility criteria, search, limitations and conclusions; and the 6 low-quality ( ≤20. 5 points) reporting items were structured summary, protocol and registration, synthesis of results, additional analysis (No. 16), additional analysis (No.23 ) and summary of evidence. Through the analysis, it is found that the report quality of intervention-related systematic reviews or Me- ta-analysis published in China Journal of Chinese Materia Medica is medium, and it is necessary to improve the quality standard of the report.
作者 张燕 于丹丹 崔德华 廖星 国华 ZHANG Yan1, YU Dan-dan2, CUI De-hua3 , LIAO Xing2, GUO Hun4(1. Editorial Office of China Journal of Chinese Materia Medica, Beijing 100700, China; 2. Institutg of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, 3. Beijing University of Chinese Medicine, Beijing 100029, China; 4. Graduate School of Stzutent Affairs, China Academy of Chinese Medical Scielwes, Beijing 100700, Chin)
出处 《中国中药杂志》 CAS CSCD 北大核心 2018年第6期1254-1260,共7页 China Journal of Chinese Materia Medica
基金 国家自然科学基金面上项目(81774159) 中央级公益性科研院所基本科研业务费专项(第十一批z0542)
关键词 系统评价/META分析 文献质量评价 PRISMA声明 systematic review or Meta-analysis quality evaluation the PRISMA statement
  • 相关文献

参考文献12

二级参考文献217

共引文献322

同被引文献154

引证文献8

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部